Pediatric medulloblastoma: Toxicity of current treatment and potential role of protontherapy
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 35 (1), 79-96
- https://doi.org/10.1016/j.ctrv.2008.09.002
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- Timing of radiation in children with medulloblastoma/PNETPediatric Blood & Cancer, 2007
- Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP studyEuropean Journal of Cancer, 2006
- Mapping radiation dose distribution on the fractional anisotropy map: Applications in the assessment of treatment-induced white matter injuryNeuroImage, 2006
- Cost‐effectiveness of proton radiation in the treatment of childhood medulloblastomaCancer, 2005
- Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastomaInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1996
- M4 protocol for cerebellar medulloblastoma: Supratentorial radiotherapy may not be avoidedInternational Journal of Radiation Oncology*Biology*Physics, 1992
- CANCER IN OFFSPRING OF LONG-TERM SURVIVORS OF CHILDHOOD AND ADOLESCENT CANCERThe Lancet, 1987
- Long-term endocrine sequelae after treatment of medulloblastoma: Prospective study of growth and thyroid functionThe Journal of Pediatrics, 1986
- Effects of cranial radiation on hearing in children with acute lymphocytic leukemiaThe Journal of Pediatrics, 1980